Innovative Medical Device Solutions Company. We think outside the box. Portfolio of Vascular, Respiratory and Consumer Medical Devices, what's next? $TBRIF
Therma Bright Sells an Additional 200-Units of Venowave(TM) to Strategic Distribution Partner Gen-X Med https://t.co/phjJFxVMA9 $TBRIF $THRM.V #Venowave#CVI#DVT#Bloodclots
Therma Bright Expands Relationship with Distribution Partner Gen-X Med for Venowave Sales
https://t.co/rxnzjvgB50
$THRM $TBRIF #Venowave#CVI#DVT#Bloodclots#Compression
Therma Bright Welcomes Healthcare and Technology Expert Steve Raysely to its Advisory Board.
https://t.co/SCf8yq3bvU
$TBRIF $THRM.V #Venowave#PreventBloodClots#DVT#CVI#DVI
Therma Bright Secures Purchase Order For Initial 100 Venowave Units From New National Distribution Partner - Valor Medical of San Antonio $TBRIF $THRM.V #Venowave#LegSwelling#PostOpPain#DVT#CVI#DVI
https://t.co/SfJdzbvmg7
Therma Bright Announces Significant Milestone with Venowave as Distribution Partners Achieve 100% HCPCS Code Reimbursement In Under 60 Days #legcompression#swelling#legpain#preventbloodclots#venowave $TBRIF $THRM.V
https://t.co/WLpVqBHtSW
We're thrilled to share that Venowave has received HCPCS and CPT Code E0683 from the Centers of Medicare & Medicaid Services along with a new unique HCPCS Level II code designation, and the final pricing determination!
https://t.co/J9w9rIs3JU
$TBRIF $THRM #Venowave
What is Therma Bright?
Listen as Rob Fia, CEO of Therma Bright, provides a company overview and a look ahead at what's to come!
#MedicalDevice#TBRIF#THRM
As a developer and partner in a range of leading edge, proprietary diagnostic and medical device technologies, Therma Bright is looking ahead to all of the incredible developments in its future.
https://t.co/KEeXsgiBJq
#MedicalDevice $TBRIF $THRM
Listen as Steven Van Metre's dives into Therma Bright's recent news, the motivated leadership team, and describes the Company as an βincredible long term opportunity.β
https://t.co/xEXVaBR7Zn
$TBRIF $THRM #Venowave#DVT#PreventBloodClots
Therma Bright Expands InStatin Investment.
InStatin is developing a novel solution using inhaled statins for the treatment and management of patients with chronic lung conditions, such as asthma and COPD.
https://t.co/MFpRDHuRit
#InStatin $TBRIF $THRM